Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 14 Multiple Myeloma 12 Pain, Postoperative 9 Neoplasms 9 Agnosia 8 Lymphoma, Non-Hodgkin 6 Lung Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Cancer Pain 5 Neoplasm Metastasis 4 Lymphoma 4 Leukemia 4 Hodgkin Disease 4 Head and Neck Neoplasms 4 Burkitt Lymphoma 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lymphoma, B-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Hairy Cell 3 Hematologic Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Trigger Finger Disorder 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Mantle-Cell 2

Interventions

resiniferatoxin 3 Ketamine 3 Morphine 2 Methadone 2 Dexmedetomidine 2 ziconotide 1 substance P-saporin 1 Standard of Care 1 Sodium Chloride 1 Ropivacaine 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Midazolam 1 Lidocaine 1 Infusion Pumps, Implantable 1 Hydromorphone 1 Fentanyl 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain, Intractable × Acetaminophen × Clear all

NCT04096391 2022-05-18

Prosper-001

Evolve Restorative Center

Phase NA Completed

Pain, Intractable, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡